Open AccessSurvey of low ER-positive expression and its correlation with other clinical and pathological factors in breast cancer
Author(s) -
Atena Azami,
Seyed Hamid Madani,
Somayeh Khazaei,
Babak Izadi,
Elahe Saleh,
Soraya Sajadimajd
Publication year - 2020
Publication title -
indian journal of pathology and microbiology/indian journal of pathology and microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.217
H-Index - 31
eISSN - 0974-5130
pISSN - 0377-4929
DOI - 10.4103/ijpm.ijpm_255_17
Subject(s) - immunohistochemistry , breast cancer , estrogen receptor , her2/neu , medicine , lymph node , pathological , cancer , pathology , oncology , progesterone receptor , breast carcinoma , estrogen
Breast cancer is the most common cancer in women. Owning to the prominent role of biomarkers in molecular classification of breast cancer in recent years, evaluation of estrogen receptor (ER), progesterone receptor (PR), and Her2/neu seems to be required for prognosis and treatment of patients.